Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods

Singh, Ravindra P.; Marwaha, Neelam; Malhotra, Pankaj; Dash, Sumitra
July 2009
Asian Journal of Transfusion Science;Jul-Dec2009, Vol. 3 Issue 2, p86
Academic Journal
Background: Platelet rich plasma-platelet concentrate (PRP-PC), buffy coat poor-platelet concentrate (BC-PC), and apheresis- PC were prepared and their quality parameters were assessed. Study Design: In this study, the following platelet products were prepared: from random donor platelets (i) platelet rich plasma - platelet concentrate (PRP-PC), and (ii) buffy coat poor- platelet concentrate (BC-PC) and (iii) single donor platelets (apheresis-PC) by different methods. Their quality was assessed using the following parameters: swirling, volume of the platelet concentrate, platelet count, WBC count and pH. Results: A total of 146 platelet concentrates (64 of PRP-PC, 62 of BC-PC and 20 of apheresis-PC) were enrolled in this study. The mean volume of PRP-PC, BC-PC and apheresis-PC was 62.30±22.68 ml, 68.81±22.95 ml and 214.05±9.91 ml and ranged from 22-135 ml, 32-133 ml and 200-251 ml respectively. The mean platelet count of PRP-PC, BC-PC and apheresis-PC was 7.6±2.97 x 1010/unit, 7.3±2.98 x 1010/unit and 4.13±1.32 x 1011/unit and ranged from 3.2-16.2 x 1010/unit, 0.6-16.4 x 1010/unit and 1.22-8.9 x 1011/unit respectively. The mean WBC count in PRP-PC (n = 10), BC-PC (n = 10) and apheresis-PC (n = 6) units was 4.05±0.48 x 107/unit, 2.08±0.39 x 107/unit and 4.8±0.8 x 106/unit and ranged from 3.4 -4.77 x 107/unit, 1.6-2.7 x 107/unit and 3.2 - 5.2 x 106/unit respectively. A total of 26 units were analyzed for pH changes. Out of these units, 10 each were PRP-PC and BC-PC and 6 units were apheresis-PC. Their mean pH was 6.7±0.26 (mean±SD) and ranged from 6.5 - 7.0 and no difference was observed among all three types of platelet concentrate. Conclusion: PRP-PC and BC-PC units were comparable in terms of swirling, platelet count per unit and pH. As expected, we found WBC contamination to be less in BC-PC than PRP-PC units. Variation in volume was more in BC-PC than PRP-PC units and this suggests that further standardization is required for preparation of BC-PC. As compared to the above two platelet concentrates, all the units of apheresis-PC fulfilled the desired quality control criteria of volume. Apheresis-PC units showed better swirling and platelet count than PRP-PCs and BC-PCs. All the platelet concentrates units had pH well above the recommended norm.


Related Articles

  • Author Reply to... Robert Zimmermann, Jürgen Zingsem, Reinhold Eckstein, Jörg Mezger. Wandt, Hannes; Schäfer-Eckart, Kerstin; Greinacher, Andreas // Deutsches Aerzteblatt International;7/20/2015, Vol. 112 Issue 29/30, p506 

    The article offers information on several studies which reveals that the risk for hemorrhage varies between thrombocytopenia patients. Topics discussed include reduced risk of hemorrhage in autologous stem cell transplantation, intensive treatment of promyelocytic leukemia patients with platelet...

  • Comparison of plateletpheresis on three continuous flow cell separators. Tendulkar, Anita; Rajadhyaksha, Sunil B. // Asian Journal of Transfusion Science;Jul-Dec2009, Vol. 3 Issue 2, p73 

    Introduction: Platelet concentrate (PC) remains one of the most important support measures in thrombocytopenic patients. An efficient cell separator is a prerequisite for an optimally functioning apheresis setup. Donor blood count may undergo a temporary reduction after the procedure. Aim: The...

  • HPA-genotyping and antiplatelet antibodies in female blood donors. Boehlen, Françoise; Bulla, Oana; Michel, Martine; Reber, Guido; de Moerloose, Philippe // Hematology Journal;2003, Vol. 4 Issue 6, p441 

    Cases of passive alloimmune thrombocytopenia have been reported due to transfusions of blood products with antiplatelet antibodies. The aim of our study was to search for antiplatelet antibodies in HPA-homozygous blood donor women once pregnant and also to perform, in case of positivity, a...

  • THE EFFECT OF LONG-TERM REGULAR PLATELETPHERESIS ON DONOR PLATELET COUNTS. M., Rapiaah; T. M., Roshan; L., Naing; A., Rehman; S. A., Ahmed; H., Roslin; S. H., Lim // Malaysian Journal of Medical Sciences;Jan2007 Supplement, Vol. 14, p122 

    Introduction: Plateletpheresis is used to obtain large numbers of platelets from random volunteer donors. One unit of plateletapheresis is equal to 4 to 6 random donor platelets. Because large numbers of platelet have been collected, transient but significant decreases in donors' platelet counts...

  • Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia. Kuter, David J.; Rummel, Mathias; Boccia, Ralph; Macik, B. Gail; Pabinger, Ingrid; Selleslag, Dominik; Rodeghiero, Francesco; Chong, Beng H.; Xuena Wang; Berger, Dietmar P. // New England Journal of Medicine;11/11/2010, Vol. 363 Issue 20, p1889 

    Background: Romiplostim, a thrombopoietin mimetic, increases platelet counts in patients with immune thrombocytopenia, with few adverse effects. Methods: In this open-label, 52-week study, we randomly assigned 234 adult patients with immune thrombocytopenia, who had not undergone splenectomy, to...

  • Improving outcomes in thrombocytopaenia. Pinn, Stephen // British Journal of Hospital Medicine (17508460);Feb2009, Vol. 70 Issue 2, p71 

    The article reports on the study done by Puget Sound Blood Center, Seattle, Washington, which states that, low-dose platelet transfusion strategy can be used for patients suffering from hypoproliferative thrombocytopaenia. The study named "Effects of Prophylactic Platelet Dose on Transfusion...

  • Assessment of plateletphersis donation in Tehran Blood Center. Chegini, A.; Mirrezaie, M.; Poorreza, M.; Rezaie, A. R.; Anbardan, A. J. // Scientific Journal of Iranian Blood Transfusion Organization;Summer2013, Vol. 10 Issue 2, p140 

    Background and Objectives Additional and more effective platelets can be gained through plateletphersis which at times equals platelets of 8 units of blood. Patients are exposed to a less number of donors through prescription of such platelets. Although side-effects of plateletphersis are low...

  • Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis. Liesveld, J; Pawlowski, J; Chen, R; Hyrien, O; Debolt, J; Becker, M; Phillips, G; Chen, Y // Bone Marrow Transplantation;May2013, Vol. 48 Issue 5, p691 

    Successful utilization of SCT modalities often requires utilization of both red cell and platelet transfusions. In this retrospective evaluation of clinical factors affecting transplant engraftment and transfusion utilization at a single transplant center in 505 patients from 2005 through 2009,...

  • Initial Values of Donor Hematocrit and Efficiency of Plateletpheresis. Landzo, Elvedin; Sofo-Hafizovic, Alma; Cetkovic-Basic, Vesna // Acta Informatica Medica;2013, Vol. 21 Issue 2, p116 

    Introduction: The collection of platelets by apheresis is considered as a very great progress in transfusion medicine. A larger yield (total number of collected plateiets) is obtained if the donor has a greater number of initial platelets and if the separation is done in a shorter time. One of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics